Robinson Capital Management’s PepperLime Health Acquisition Corporation Warrrant PEPLW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,516
Closed -$53 235
2023
Q4
$53 Sell
1,516
-156
-9% -$4 ﹤0.01% 202
2023
Q3
$55 Sell
1,672
-3,914
-70% -$247 ﹤0.01% 232
2023
Q2
$324 Buy
5,586
+2,768
+98% +$149 ﹤0.01% 228
2023
Q1
$268 Buy
2,818
+150
+6% +$13 ﹤0.01% 262
2022
Q4
$41 Hold
2,668
﹤0.01% 333
2022
Q3
$0 Buy
2,668
+343
+15% +$50 ﹤0.01% 344
2022
Q2
$0 Buy
+2,325
New +$952 ﹤0.01% 351

Other funds holding PEPLW

Robinson Capital Management's PEPLW Position: Q1 2024 in Review

Robinson Capital Management sold out of PepperLime Health Acquisition Corporation Warrrant (PEPLW) in Q1 2024, closing a stake of 1,516 shares — an estimated $53 sold.

Robinson Capital Management first reported a position in PEPLW in Q2 2022 and held it in 7 quarters. The position peaked at $324 in Q2 2023. 1 fund tracked by Wall St. Rank holds PEPLW as of Q1 2024.

  • Robinson Capital Management reported no remaining PepperLime Health Acquisition Corporation Warrrant position as of Q1 2024 after selling out during the quarter.
  • Robinson Capital Management sold 1,516 PepperLime Health Acquisition Corporation Warrrant shares in Q1 2024, an estimated $53.
  • Robinson Capital Management first reported a position in PepperLime Health Acquisition Corporation Warrrant in Q2 2022 and held it in 7 quarters.
  • Robinson Capital Management's PepperLime Health Acquisition Corporation Warrrant position peaked at $324 in Q2 2023.
  • 1 fund tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Warrrant as of Q1 2024.

Based on Robinson Capital Management's 13F filing for Q1 2024, filed 14 May 2024.